Answers are grounded in this paper and cite their sources.
DOPA-derived peptidomimetics are an attractive therapeutic tool for the treatment of Parkinson's disease.
No takes yet. Share an insight, caveat, or question.
Bizzarri et al. (2017) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: